NDT Advance Access originally published online on October 25, 2005
Nephrology Dialysis Transplantation 2006 21(2):478-482; doi:10.1093/ndt/gfi212
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Original Articles: Dialysis and Transplantation
The course of type 1 hepato-renal syndrome post liver transplantation
1 Department of Critical Care Medicine and 3 Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, 2 Division of Pulmonary and Critical Care Medicine, Thomas Jefferson University, Philadelphia, PA, USA
Correspondence and offprint requests to: Paul E. Marik, MD, FCCP, Chief of Pulmonary and Critical Care Medicine, Thomas Jefferson University, 1015 Chestnut Street, Suite M 100, Philadelphia, PA, 19107. Email: paul.marik{at}jefferson.edu
Background. Hepato-renal syndrome (HRS) is a functional form of renal failure that occurs in patients with end-stage liver disease. Previously considered fatal without liver transplantation, treatment with vasoconstrictors and albumin has been demonstrated to improve renal function in patients with type 1 HRS. Liver transplantation is still considered the definitive treatment for HRS. However, the renal recovery rate and those factors that predict recovery post orthotopic liver transplantation have not been determined.
Methods. We reviewed the hospital course of 28 patients who met the International Ascites Club criteria for type I HRS and who underwent orthotopic liver transplant. The patients’ demographic and pre- and post-operative laboratory data were recorded; patients were followed for 4 months post-transplantation or until death.
Results. The MELD score of the patients was 30±6. The mean duration of HRS prior to liver transplantation was 37±27 days. HRS resolved in 16 patients (58%). The mean time to resolution of HRS was 21±27 days, with a range of 4–110 days. Eight (50%) patients in whom the HRS resolved were undergoing pre-transplantation dialysis. The age of the recipients (49±10 vs 56±12; P = 0.05), the total bilirubin level on post-operative day 7 (6.0±4.3 vs 10.1±5.9 mg/dl; P = 0.04), alcoholic liver disease and the requirement for post-transplant dialysis were predictors of resolution of HRS by univariate analysis. Only alcoholic liver disease and post-transplant dialysis were independent (negative) predictors of resolution of HRS. Seven of the 12 (58%) patients who developed chronic renal insufficiency remained dialysis dependent. The pre-operative serum creatinine was non-significantly higher in the non-resolvers who remained dialysis dependent compared to those who did not require long-term dialysis (3.0±1.0 vs 2.3±0.4 mg/dl; P = 0.1) Four patients died; in three of these patients the HRS had resolved prior to their death.
Conclusion. HRS is not always cured by orthotopic liver transplant. Pre-transplantation dialysis or a long waiting period should not preclude transplantation in patients with HRS. HRS may not resolve in patients with alcoholic liver disease. We were unable to accurately define that group of patients with HRS who required long-term dialysis and could theoretically benefit from combined liver–kidney transplantation.
Keywords: cirrhosis; dialysis; hepato–renal syndrome; liver transplantation; renal failure
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Gines and R. W. Schrier Renal Failure in Cirrhosis N. Engl. J. Med., September 24, 2009; 361(13): 1279 - 1290. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Salerno, A. Gerbes, P. Gines, F. Wong, and V. Arroyo Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis Postgrad. Med. J., December 1, 2008; 84(998): 662 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Salerno, A. Gerbes, P. Gines, F. Wong, and V. Arroyo Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis Gut, September 1, 2007; 56(9): 1310 - 1318. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schepke Hepatorenal syndrome: current diagnostic and therapeutic concepts Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_8): viii2 - viii4. [Full Text] [PDF]
|
|